Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision

NCT02167321 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: Arm A : standard neoadjuvant chemoradiotherapy group
DRUG: Arm B : adjuvant FOLFOX group

Sponsor

Yonsei University